In some European countries (Germany, Spain, Austria), private or public health insurance may cover cell therapy for hip OA if standard treatments (physical therapy, NSAIDs, corticosteroid injection) have failed and the patient is not yet a candidate for joint replacement. In the United States and UK, insurance does not cover it; patients self-fund or explore treatment abroad.
Hip intra-articular cell injection costs €3,500–6,000 per treatment session, reflecting fluoroscopic guidance, joint-space access, cell preparation, and sterile protocols. Imaging—baseline and follow-up MRI or CT—adds €1,200–2,000. Many participants undergo two to three injections spaced 8–12 weeks apart to achieve optimal effect, bringing total cost to €10,000–18,000 or more. Physiotherapy guidance post-injection is advisable, adding further expense.
Am I a candidate? → · Hip Osteoarthritis: full overview → · Hip Osteoarthritis cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Dr Tymur Lukyanenko (Orthopaedic Traumatologist · 20+ yrs clinical, 15+ yrs cell therapy) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite